Table 1.
Demographic and other clinical information of the two study cohorts.
|
||||||
---|---|---|---|---|---|---|
n | Age Mean years ±SEMa |
Female n (%) |
African American n (%) |
BMI | Smoking status n (%) |
|
Cohort 1 - Sheppard Pratt, Baltimore, MD, USA | ||||||
Controls | 78 | 34.4±1.4 | 56 (71.8) | 31 (39.7) | - | 14 (17.9) |
Schizophrenia | 141 | 40.36±0.9b | 56 (39.7)d | 65 (46.1) | 30.54±0.61 | 83 (58.9)g |
Bipolar disorder | 75 | 35.1±1.4 | 52 (69.3) | 18 (24.0)e | 27.17±0.77f | 26 (34.7)h |
Cohort 2 - University of Cologne, Cologne, Germany | ||||||
First-episode schizophrenia - medicated |
38 | 36.4±2.3 | 20 (52.6) | - | - | - |
First-episode schizophrenia - unmedicated |
78 | 29.9±1.1c | 31 (39.7) | - | - | - |
SEM refers to standard error of the mean
t=−3.69, p<0.0003
t=2.94, p<0.004
chi2=20.68, p<0.001
chi2=4.35, p<0.04
t=−3.43, p<0.0007; n=121 schizophrenia, n=74 bipolar disorder
chi2=34.07, p<0.001
chi2=5.53, p<0.02